These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1485130)
1. [Antiperinuclear antibodies and corrisponding antigens]. Youinou P; Berthelot JM; Péron A; Leroux AM; Le Goff P Rev Rhum Mal Osteoartic; 1992 Sep; 59(6 Pt 2):43S-51S. PubMed ID: 1485130 [TBL] [Abstract][Full Text] [Related]
2. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients]. Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Janssens X; Veys EM; Verbruggen G; Declercq L J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971 [TBL] [Abstract][Full Text] [Related]
4. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis. Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850 [TBL] [Abstract][Full Text] [Related]
5. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470 [TBL] [Abstract][Full Text] [Related]
6. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. Sebbag M; Simon M; Vincent C; Masson-Bessière C; Girbal E; Durieux JJ; Serre G J Clin Invest; 1995 Jun; 95(6):2672-9. PubMed ID: 7539459 [TBL] [Abstract][Full Text] [Related]
7. Antiperinuclear factor, a rheumatoid arthritis specific autoantibody: its relation to Epstein-Barr virus. Westgeest AA; van Loon AM; van der Logt JT; van de Putte LB; Boerbooms AM J Rheumatol; 1989 May; 16(5):626-30. PubMed ID: 2547060 [TBL] [Abstract][Full Text] [Related]
8. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis. Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364 [TBL] [Abstract][Full Text] [Related]
9. Antiperinuclear factor in an Italian series of patients with rheumatoid arthritis. Cassani F; Ferri S; Bianchi FB; Marsili R; Zauli D; Pisi E Ric Clin Lab; 1983; 13(3):347-52. PubMed ID: 6606208 [TBL] [Abstract][Full Text] [Related]
10. Specificity of antiperinuclear factor for rheumatoid arthritis in rheumatoid factor-positive sera. Berthelot JM; Maugars Y; Audrain M; Youinou P; Prost A Br J Rheumatol; 1995 Aug; 34(8):716-20. PubMed ID: 7551653 [TBL] [Abstract][Full Text] [Related]
11. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821 [TBL] [Abstract][Full Text] [Related]
12. The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Sondag-Tschroots IR; Aaij C; Smit JW; Feltkamp TE Ann Rheum Dis; 1979 Jun; 38(3):248-51. PubMed ID: 384931 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature. Berthelot JM; Garnier P; Glémarec J; Flipo RM Rev Rhum Engl Ed; 1998 Jan; 65(1):9-14. PubMed ID: 9523380 [TBL] [Abstract][Full Text] [Related]
14. The reliability of the antiperinuclear factor test despite the inconstancy of the targeted antigens. Youinou P; Le Goff P J Rheumatol; 1994 Nov; 21(11):1990-1. PubMed ID: 7869299 [No Abstract] [Full Text] [Related]
15. [Evaluation of the antiperinuclear factor (APF)]. Nienhuis RL Ned Tijdschr Geneeskd; 1973 Oct; 117(42):1561-5. PubMed ID: 4545001 [No Abstract] [Full Text] [Related]
16. The antiperinuclear factor. I. Clinical and serologic associations. Youinou P; Le Goff P; Dumay A; Lelong A; Fauquert P; Jouquan J Clin Exp Rheumatol; 1990; 8(3):259-64. PubMed ID: 1696191 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
18. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis? Saraux A; Valls I; Voisin V; Koreichi A; Baron D; Youinou P; Le Goff P Rev Rhum Engl Ed; 1995 Jan; 62(1):16-20. PubMed ID: 7540486 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141 [TBL] [Abstract][Full Text] [Related]
20. The antiperinuclear factor and antikeratin antibody systems. Youinou P; Serre G Int Arch Allergy Immunol; 1995 Aug; 107(4):508-18. PubMed ID: 7542514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]